Kathryn Garner

Kathryn Garner

Company: Newcells Biotech

Job title: Head of Kidney Development


A Human Primary in vitro Model of the Glomerular Filtration Barrier for Disease Modelling 3:00 pm

Primary podocyte model maintains high marker expression, including Nephrin, Podocin, WT1, and CD2AP TNF sensitivity leads to de-differentiation and decreased barrier integrity, with no effect on 70 kDa FITC-dextran permeability or cell viability Co-culture with Glomerular Microvascular Endothelial Cells presents an in vivo-like environment for disease modellingRead more

day: Day 1 Track 1 PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.